Trevi Therapeutics TRVI
NASDAQ TRVI
$12.94 +0.17 (+1.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Price to Sales (2019 - 2024)

Updated

Analysis

Trevi Therapeutics (TRVI) Price to Sales (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Trevi Therapeutics 1.84 Bn 969.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 70.80
Mar 31, 2024 75.88
Dec 31, 2023 27.95
Sep 30, 2023 45.80
Jun 30, 2023 59.43
Mar 31, 2023 61.69
Dec 31, 2022 66.49
Sep 30, 2022 143.48
Jun 30, 2022 820.17
Mar 31, 2022 6,161.16
Dec 31, 2021 1,781.64
Sep 30, 2021 2,360.50
Jun 30, 2021 4,023.66
Mar 31, 2021 2,248.67
Dec 31, 2020 252.15
Sep 30, 2020 185.05
Jun 30, 2020 173.76
Mar 31, 2020 65.85
Dec 31, 2019 55.57
Sep 30, 2019 130.92
API Access

Trevi Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=TRVI&period=max&api_key=YOUR_API_KEY